Arenas and colleagues [180] reported that midbrain dopaminergic neurons of PD patients had lower levels of nuclear NFE2L1 compared to healthy controls, and that cultured dopaminergic neurons with an NFE2L1 knockdown were sensitized to caspase-3 activation under conditions of oxidative stress. The gene discussed is NFE2L1; the disease is Parkinson disease.